These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27475881)

  • 1. Hydrogen sulfide-releasing anti-inflammatory drugs for chemoprevention and treatment of cancer.
    Ianaro A; Cirino G; Wallace JL
    Pharmacol Res; 2016 Sep; 111():652-658. PubMed ID: 27475881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen sulfide-based anti-inflammatory and chemopreventive therapies: an experimental approach.
    Flannigan KL; Wallace JL
    Curr Pharm Des; 2015; 21(21):3012-22. PubMed ID: 26004409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventative potential.
    Gemici B; Elsheikh W; Feitosa KB; Costa SK; Muscara MN; Wallace JL
    Nitric Oxide; 2015 Apr; 46():25-31. PubMed ID: 25461269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APCMin/+ Mouse Model of Intestinal Tumorigenesis.
    Paul-Clark M; Elsheikh W; Kirkby N; Chan M; Devchand P; Agbor TA; Flannigan KL; Cheadle C; Freydin M; Ianaro A; Mitchell JA; Wallace JL
    PLoS One; 2016; 11(2):e0147289. PubMed ID: 26910063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory and cytoprotective properties of hydrogen sulfide.
    Gemici B; Wallace JL
    Methods Enzymol; 2015; 555():169-93. PubMed ID: 25747480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling.
    Kodela R; Nath N; Chattopadhyay M; Nesbitt DE; Velázquez-Martínez CA; Kashfi K
    Drug Des Devel Ther; 2015; 9():4873-82. PubMed ID: 26346117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer.
    Elsheikh W; Blackler RW; Flannigan KL; Wallace JL
    Nitric Oxide; 2014 Sep; 41():131-7. PubMed ID: 24747869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention.
    Fajardo AM; Piazza GA
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(2):G59-70. PubMed ID: 26021807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen sulfide-releasing anti-inflammatory drugs.
    Wallace JL
    Trends Pharmacol Sci; 2007 Oct; 28(10):501-5. PubMed ID: 17884186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen sulfide-based therapeutics and gastrointestinal diseases: translating physiology to treatments.
    Chan MV; Wallace JL
    Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(7):G467-73. PubMed ID: 23868410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer.
    Wechter WJ; Kantoci D; Murray ED; Quiggle DD; Leipold DD; Gibson KM; McCracken JD
    Cancer Res; 1997 Oct; 57(19):4316-24. PubMed ID: 9331093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An emerging role for anti-inflammatory agents for chemoprevention.
    Chan AT; Detering E
    Recent Results Cancer Res; 2013; 191():1-5. PubMed ID: 22893197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics.
    Wallace JL; Blackler RW; Chan MV; Da Silva GJ; Elsheikh W; Flannigan KL; Gamaniek I; Manko A; Wang L; Motta JP; Buret AG
    Antioxid Redox Signal; 2015 Feb; 22(5):398-410. PubMed ID: 24635322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
    Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
    Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat.
    Wallace JL; Caliendo G; Santagada V; Cirino G; Fiorucci S
    Gastroenterology; 2007 Jan; 132(1):261-71. PubMed ID: 17241876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications.
    Kodela R; Chattopadhyay M; Velázquez-Martínez CA; Kashfi K
    Biochem Pharmacol; 2015 Dec; 98(4):564-72. PubMed ID: 26394025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrogen sulfide: from physiology to pharmacology.
    Fiorucci S
    Inflamm Allergy Drug Targets; 2011 Apr; 10(2):77-84. PubMed ID: 21275895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic applications of organosulfur compounds as novel hydrogen sulfide donors and/or mediators.
    Gu X; Zhu YZ
    Expert Rev Clin Pharmacol; 2011 Jan; 4(1):123-33. PubMed ID: 22115353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of intestinal tumorigenesis by nabumetone: induction of apoptosis and Bcl-2 downregulation.
    Roy HK; Karoski WJ; Ratashak A; Smyrk TC
    Br J Cancer; 2001 May; 84(10):1412-6. PubMed ID: 11355956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2.
    Dannenberg AJ; Zakim D
    Semin Oncol; 1999 Oct; 26(5):499-504. PubMed ID: 10528897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.